Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Horizon Therapeutics (NQ: HZNP ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Oct 5, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Horizon Therapeutics < Previous 1 2 ... 10 11 12 13 14 15 16 17 Next > Horizon Therapeutics plc to Participate in Upcoming Investor Conferences December 23, 2021 From Horizon Therapeutics plc Via Business Wire Alpine Immune Sciences and Horizon Therapeutics plc Announce Exclusive License and Collaboration Agreement to Develop Novel Protein-Based Therapies for Autoimmune and Inflammatory Diseases December 16, 2021 From Alpine Immune Sciences, Inc. and Horizon Therapeutics plc Via Business Wire This Biotech CEO Is Trying To Cure His Son's Rare Disease December 09, 2021 Few questions stump Tim Walbert. But the Horizon Therapeutics CEO is still working to answer one of them from his son. Via Investor's Business Daily Horizon Therapeutics plc Makes $100,000 Seed Donation to Support Fundraising Efforts to Renovate Emmett Till’s Home into a Museum and Theater December 02, 2021 From Horizon Therapeutics plc Via Business Wire Benzinga's Top Ratings Upgrades, Downgrades For December 8, 2021 December 08, 2021 Upgrades According to Deutsche Bank, the prior rating for Goodyear Tire & Rubber Co (NASD... Via Benzinga Great Place to Work Names Horizon Therapeutics plc to Best Workplaces for Parents List December 02, 2021 From Horizon Therapeutics plc Via Business Wire Horizon Therapeutics plc Provides Academic Scholarships to Help Economically Disadvantaged Students in Ireland Further Their STEM Education December 01, 2021 From Horizon Therapeutics plc Via Business Wire 7 Drug Stocks to Buy Now While They’re Still on Sale November 30, 2021 Covid-19 stocks soared to unsustainable highs as investors ignored drug stocks with a deep pipeline of products for the decade ahead. Via InvestorPlace Topics Supply Chain Exposures COVID-19 Supply Chain New Analysis Published in Multiple Sclerosis and Related Disorders Supports the Efficacy of UPLIZNA® (inebilizumab-cdon) in Patients Previously Treated with Rituximab for Neuromyelitis Optica Spectrum Disorder (NMOSD) November 22, 2021 From Horizon Therapeutics plc Via Business Wire Benzinga's Top Ratings Upgrades, Downgrades For November 19, 2021 November 19, 2021 Upgrades Morgan Stanley upgraded the previous rating for EQT Corp (NYSE: Via Benzinga Horizon Therapeutics Recognizes Second Annual Thyroid Eye Disease (TED) Awareness Week with New Educational and Community Building Initiative November 15, 2021 From Horizon Therapeutics plc Via Business Wire New Real-World Data Show High Rate of Patient Adherence to TEPEZZA® (teprotumumab-trbw) for Thyroid Eye Disease (TED) November 12, 2021 From Horizon Therapeutics plc Via Business Wire Horizon Therapeutics plc Announces First Patient Enrolled in Phase 2b Pivotal Trial Evaluating HZN-825 for the Treatment of Diffuse Cutaneous Systemic Sclerosis November 09, 2021 From Horizon Therapeutics plc Via Business Wire Horizon Therapeutics plc to Participate in Upcoming Investor Conferences November 08, 2021 From Horizon Therapeutics plc Via Business Wire Stock Market Rally Keeps Running On Tesla, Nvidia, Fed Decision, Jobs Report: Weekly Review November 05, 2021 But the Nasdaq is starting to look extended. Via Investor's Business Daily Topics Bonds Economy Stocks Exposures COVID-19 Debt Markets Interest Rates Horizon Therapeutics plc Receives Top Workplace Awards in Chicago and San Francisco November 05, 2021 From Horizon Therapeutics plc Via Business Wire Results from PROTECT Trial Evaluating KRYSTEXXA® (pegloticase injection) in Kidney Transplant Recipients with Uncontrolled Gout Presented as Part of American Society of Nephrology (ASN) Kidney Week November 04, 2021 From Horizon Therapeutics plc Via Business Wire Horizon Therapeutics's Return On Capital Employed Insights November 04, 2021 According to Benzinga Pro, during Q3, Horizon Therapeutics (NASDAQ:HZNP) earned $331.54 million, a 142.86% increase from the preceding quarter. Horizon Therapeutics also posted a... Via Benzinga Horizon Pharma plc (HZNP) Q3 2021 Earnings Call Transcript November 03, 2021 HZNP earnings call for the period ending September 30, 2021. Via The Motley Fool Topics Earnings Exposures Financial CFO Retirement Plan Undoes Horizon Therapeutics Stock After Beat-And-Raise November 03, 2021 Chief Financial Officer Paul Hoelscher will retire on May 16. Via Investor's Business Daily Topics Retirement Exposures Pension The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering November 03, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Horizon Announces Retirement Of CFO, Beat-and-raise Q3 Horizon Therapeutics... Via Benzinga Topics Retirement Exposures Pension Horizon Therapeutics plc Announces Chief Financial Officer Succession Plan November 03, 2021 From Horizon Therapeutics plc Via Business Wire Horizon Therapeutics plc Reports Record Third-Quarter 2021 Financial Results; Increasing Full-Year 2021 Net Sales and Adjusted EBITDA Guidance November 03, 2021 From Horizon Therapeutics plc Via Business Wire New Data Being Presented at American College of Rheumatology Convergence 2021 Highlight Horizon’s Commitment to Improving Outcomes for People Living with Uncontrolled Gout November 01, 2021 From Horizon Therapeutics plc Via Business Wire MIRROR Randomized Controlled Trial Meets Primary Endpoint and Shows 71% of Patients Achieved a Complete Response Rate Using KRYSTEXXA® (pegloticase injection) with Methotrexate October 25, 2021 From Horizon Therapeutics plc Via Business Wire The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline October 31, 2021 Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc... Via Benzinga Horizon Therapeutics plc Named to Newsweek’s List of the Most Loved Workplaces for 2021 October 22, 2021 From Horizon Therapeutics plc Via Business Wire Newly Published Data Continue to Support Long-Term Efficacy of TEPEZZA® (teprotumumab-trbw) for Thyroid Eye Disease (TED) October 21, 2021 From Horizon Therapeutics plc Via Business Wire New Data Reinforce the Relationship Between B-Cell Depletion and Improved Outcomes in People Receiving UPLIZNA® (inebilizumab-cdon) for Neuromyelitis Optica Spectrum Disorder (NMOSD) October 13, 2021 From Horizon Therapeutics plc Via Business Wire Beam Therapeutics Stock Flashes Renewed Technical Strength October 12, 2021 On Tuesday, Beam Therapeutics stock reached an key performance benchmark, seeing its RS Rating jump to 92, up from 88 the day before. Via Investor's Business Daily < Previous 1 2 ... 10 11 12 13 14 15 16 17 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.